To the editor: This transfer to invoke tariffs on prescription drugs might increase the price of healthcare for all the nation (“Why California sufferers might quickly face larger drug costs underneath Trump’s tariff plan,” Sept. 26).
It’s a identified reality, even when President Trump refuses to acknowledge it, that the price of tariffs is basically handed alongside to the customers. Increased drug costs are thus the apparent trickle-down impact of this transfer. It’s already well-known that seniors and others on restricted incomes usually fail to have prescriptions stuffed if it’s going to end in a giant chunk out of their budgets.
We are able to anticipate little reduction from medical insurance coverage, the underwriters being basically pressured to boost premiums to cowl the elevated value of prescription drug protection. The choice — elevating the annual deductible for the insured — would probably have an equal “finances chunk” and could be rejected by many, establishing a “damned in case you do, damned in case you don’t” situation.
I personally anticipate my Half D Medicare prescription protection to implement a rise in each my premium and deductible if not this coming yr, then actually in 2027 after my insurer has needed to pay out extra because of these ill-conceived tariffs.
Congress must enact laws limiting the imposition of tariffs on merchandise important to our very existence. And it must be a bipartisan effort to make it veto-proof. In any other case, no matter social gathering affiliation, there are going to be fewer constituents to signify.
Kymberleigh Richards, Van Nuys
